Lista de obras -

A Population-Based Study on Myelodysplastic Syndromes in the Lazio Region (Italy), Medical Miscoding and 11-Year Mortality Follow-Up: the Gruppo Romano-Laziale Mielodisplasie Experience of Retrospective Multicentric Registry.

artículo científico publicado en 2017

Acute myeloid leukemia arising from chronic myelomonocytic leukemia during hypomethylating therapy

artículo científico

Advanced chronic myelomonocytic leukemia in elderly and frail patients managed by azacitidine in the field of clinical practice.

artículo científico publicado en 2017

Anticoagulant and Anti-thrombotic Treatments in the Management of Hematological Malignancies in a Home Care Program

artículo científico publicado en 2011

At-Home Application of Autologous Platelet Rich Plasma as Treatment for Pressure Sore and Related Anemia

artículo científico publicado en 2016

Authors' reply

artículo científico publicado en 2011

Azacitidine in chronic myelomonocytic leukemia: an effective and manageable approach

artículo científico

Back to the future: TFR and pregnancy in CML

artículo científico publicado en 2018

Bone marrow necrosis as a terminal complication of a very long-lasting polycythemia vera

artículo científico publicado en 2007

Case reports: zoster pain in haematological malignancies: effective pain relief with oxycodone in patients unresponsive to other analgesic measures

artículo científico publicado en 2007

Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias

artículo científico publicado en 2015

Chelation efficacy and erythroid response during deferasirox treatment in patients with myeloproliferative neoplasms in fibrotic phase

artículo científico publicado en 2015

Chronic myeloproliferative disorders: is quality-of-life the new goal?

artículo científico publicado en 2018

Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia

artículo científico publicado en 2006

Complex and multifaceted therapy-related myeloid neoplasm following laryngeal cancer treated with Cisplatin and radiotherapy.

artículo científico publicado en 2013

Controlled-release oxycodone for the treatment of bortezomib-induced neuropathic pain in patients with multiple myeloma

artículo científico publicado en 2012

Current clinical strategies and emergent treatment landscapes in leukemic transformation of Philadelphia-negative myeloproliferative neoplasms

artículo científico publicado en 2020

Decitabine treatment of multiple extramedullary acute myeloid leukemia involvements after essential thrombocytemia transformation.

artículo científico publicado en 2017

Deferasirox chelation therapy in patients with transfusion-dependent MDS: a 'real-world' report from two regional Italian registries: Gruppo Romano Mielodisplasie and Registro Basilicata.

artículo científico publicado en 2015

Diagnosis of myelodysplastic syndromes in individuals heterozygous for mutations in the α- and β-globin genes: a reminder for haematologists

artículo científico publicado en 2013

Dismal outcome of acute myeloid leukemia secondary to myelodysplastic syndrome and chronic myelomonocytic leukemia after azacitidine failure in a daily-life setting

artículo científico publicado en 2014

Double remission of simultaneously occurring secondary AML and CLL by venetoclax monotherapy

artículo científico publicado en 2019

Durable erythroid response after discontinuation of epoetin-alpha: an unexpected outcome in a patient with myelodysplastic syndrome

artículo científico publicado en 2013

Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial

artículo científico publicado en 2017

End of life care in hematology: still a challenging concern

artículo científico publicado en 2014

Evolution of chronic myelomonocytic leukemia from refractory anemia: the unusual course of a myelodysplastic syndrome

artículo científico publicado en 2013

Fulminant thrombotic microangiopathy as a clinical presentation of an occult signet-ring cell carcinoma of the lung and misdiagnosed as idiopathic thrombotic thrombocytopenic purpura.

artículo científico publicado en 2010

Gelatinous degeneration of the bone marrow: two case reports showing different hematological features and clinical outcomes

scientific article published on 21 September 2007

High-dose epoetin alfa as induction treatment for severe anemia in multiple myeloma patients

artículo científico publicado en 2009

Hodgkin lymphoma in a mutated ZAP-70 negative B-cell Chronic Lymphocytic Leukemia patient

scientific article published on 20 April 2007

Home care management of patients affected by hematologic malignancies: a review.

artículo científico publicado en 2006

IgA-induced autoimmune hemolytic anemia in a patient with antiphospholipid syndrome

artículo científico publicado en 2012

Improving accuracy of prognosis in patients with myelodysplastic syndromes using self-reported quality of life data. Opportunities for a new research agenda in developing prognostic models

artículo científico publicado en 2016

Iron-chelating therapy with deferasirox in transfusion-dependent, higher risk myelodysplastic syndromes: a retrospective, multicentre study

artículo científico publicado en 2017

Is cell therapy the answer for hematological malignancies?

artículo científico publicado en 2018

Late but effective long-term response to splenectomy in the treatment of immune thrombocytopenia

artículo científico publicado en 2013

Management of Peritoneal Dialysis within a Home Care Program for Hematological Malignancies: Concerns and Perspectives Illustrated by a Case Report.

artículo científico

Management of hematological malignancies in patients affected by renal failure ⬇️

artículo científico publicado el 1 de marzo de 2011

Managing myelodysplastic syndromes in very old patients: a teaching case report.

artículo científico publicado en 2013

Motor disability, clinical complications, quality of life, and survival in patients with cancer: a plausible scenario

artículo científico publicado en 2014

Mucositis in malignant hematology

artículo científico publicado en 2010

Mucositis in patients with hematologic malignancies: an overview.

artículo científico publicado en 2007

NOTCH1 mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation treatment.

artículo científico publicado en 2014

Opioids in pain management of blood-related malignancies.

artículo científico publicado en 2006

Pain and related complaints in patients with acute leukemia: time for simultaneous care in hemato-oncology

artículo científico publicado en 2019

Pain in blood cancers

artículo científico publicado en 2011

Pain in malignant hematology ⬇️

artículo científico publicado el 1 de febrero de 2011

Pain management in hematological patients with major organ dysfunctions and comorbid illnesses

artículo científico

Pain management in multiple myeloma.

scientific article published on March 2010

Pain syndromes in haematological malignancies: an overview

artículo científico publicado en 2004

Pain syndromes in sickle cell disease: an update

artículo científico publicado en 2009

Palifermin in the management of mucositis in hematological malignancies: current evidences and future perspectives.

artículo científico publicado en 2009

Patient-reported outcomes enhance the survival prediction of traditional disease risk classifications: An international study in patients with myelodysplastic syndromes

artículo científico publicado en 2017

Prevalence, severity and correlates of fatigue in newly diagnosed patients with myelodysplastic syndromes

artículo científico publicado en 2014

Primary acquired chronic pure red cell aplasia refractory to standard treatments: remission with rituximab.

artículo científico publicado en 2016

Primary pulmonary hodgkin lymphoma simulating a mediastinal tumour: an uncommon occurrence.

artículo científico publicado en 2013

Prognostic value of self-reported fatigue on overall survival in patients with myelodysplastic syndromes: a multicentre, prospective, observational, cohort study

artículo científico publicado en 2015

Pulmonary infections in patients with myelodysplastic syndromes receiving frontline azacytidine treatment

scientific article published on 23 January 2020

Pure erythroid leukemia in advanced breast cancer.

artículo científico

Real-life use of erythropoiesis-stimulating agents in myelodysplastic syndromes: a "Gruppo Romano Mielodisplasie (GROM)" multicenter study.

artículo científico publicado en 2016

Reciprocal absence of cross-resistance between eltrombopag and romiplostim in two patients with refractory immune thrombocytopenic purpura

artículo científico publicado en 2014

Regaining the response to erythropoietin following azacitidine in chronic myelomonocytic leukemia previously evolved from refractory anemia

artículo científico publicado en 2015

Role of immunochemotherapy in the treatment of chronic lymphocytic leukemia

artículo científico publicado en 2006

Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia.

artículo científico publicado en 2015

Steroid-refractory immune thrombocytopenia in the era of the new thrombomimetic drugs: is there still a role for rituximab?

artículo científico publicado en 2016

Systematic review of amifostine for the management of oral mucositis in cancer patients

artículo científico publicado en 2012

Systematic review of anti-inflammatory agents for the management of oral mucositis in cancer patients.

artículo científico

The management of membranous glomerulopathy in allogeneic stem cells transplantation: updated literature

artículo científico

The prevention of oral mucositis in patients with blood cancers: current concepts and emerging landscapes

artículo científico

The use of major analgesics in patients with renal dysfunction.

artículo científico publicado en 2010

Towards the integration of patient-reported outcomes into the global clinical management of multiple myeloma

scientific article published on 28 August 2019

Unexplained severe Coombs-negative hemolytic anemia during treatment of refractory chronic lymphocytic leukemia with alemtuzumab.

artículo científico publicado en 2013

Lista de obras de

A Population-Based Study on Myelodysplastic Syndromes in the Lazio Region (Italy), Medical Miscoding and 11-Year Mortality Follow-Up: the Gruppo Romano-Laziale Mielodisplasie Experience of Retrospective Multicentric Registry.

Acute myeloid leukemia arising from chronic myelomonocytic leukemia during hypomethylating therapy

Advanced chronic myelomonocytic leukemia in elderly and frail patients managed by azacitidine in the field of clinical practice.

Anticoagulant and Anti-thrombotic Treatments in the Management of Hematological Malignancies in a Home Care Program

At-Home Application of Autologous Platelet Rich Plasma as Treatment for Pressure Sore and Related Anemia

Authors' reply

Azacitidine in chronic myelomonocytic leukemia: an effective and manageable approach

Back to the future: TFR and pregnancy in CML

Bone marrow necrosis as a terminal complication of a very long-lasting polycythemia vera

Case reports: zoster pain in haematological malignancies: effective pain relief with oxycodone in patients unresponsive to other analgesic measures

Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias

Chelation efficacy and erythroid response during deferasirox treatment in patients with myeloproliferative neoplasms in fibrotic phase

Chronic myeloproliferative disorders: is quality-of-life the new goal?

Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia

Complex and multifaceted therapy-related myeloid neoplasm following laryngeal cancer treated with Cisplatin and radiotherapy.

Controlled-release oxycodone for the treatment of bortezomib-induced neuropathic pain in patients with multiple myeloma

Current clinical strategies and emergent treatment landscapes in leukemic transformation of Philadelphia-negative myeloproliferative neoplasms

Decitabine treatment of multiple extramedullary acute myeloid leukemia involvements after essential thrombocytemia transformation.

Deferasirox chelation therapy in patients with transfusion-dependent MDS: a 'real-world' report from two regional Italian registries: Gruppo Romano Mielodisplasie and Registro Basilicata.

Diagnosis of myelodysplastic syndromes in individuals heterozygous for mutations in the α- and β-globin genes: a reminder for haematologists

Dismal outcome of acute myeloid leukemia secondary to myelodysplastic syndrome and chronic myelomonocytic leukemia after azacitidine failure in a daily-life setting

Double remission of simultaneously occurring secondary AML and CLL by venetoclax monotherapy

Durable erythroid response after discontinuation of epoetin-alpha: an unexpected outcome in a patient with myelodysplastic syndrome

Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial

End of life care in hematology: still a challenging concern

Evolution of chronic myelomonocytic leukemia from refractory anemia: the unusual course of a myelodysplastic syndrome

Fulminant thrombotic microangiopathy as a clinical presentation of an occult signet-ring cell carcinoma of the lung and misdiagnosed as idiopathic thrombotic thrombocytopenic purpura.

Gelatinous degeneration of the bone marrow: two case reports showing different hematological features and clinical outcomes

High-dose epoetin alfa as induction treatment for severe anemia in multiple myeloma patients

Hodgkin lymphoma in a mutated ZAP-70 negative B-cell Chronic Lymphocytic Leukemia patient

Home care management of patients affected by hematologic malignancies: a review.

IgA-induced autoimmune hemolytic anemia in a patient with antiphospholipid syndrome

Improving accuracy of prognosis in patients with myelodysplastic syndromes using self-reported quality of life data. Opportunities for a new research agenda in developing prognostic models

Iron-chelating therapy with deferasirox in transfusion-dependent, higher risk myelodysplastic syndromes: a retrospective, multicentre study

Is cell therapy the answer for hematological malignancies?

Late but effective long-term response to splenectomy in the treatment of immune thrombocytopenia

Management of Peritoneal Dialysis within a Home Care Program for Hematological Malignancies: Concerns and Perspectives Illustrated by a Case Report.

Management of hematological malignancies in patients affected by renal failure ⬇️

Managing myelodysplastic syndromes in very old patients: a teaching case report.

Motor disability, clinical complications, quality of life, and survival in patients with cancer: a plausible scenario

Mucositis in malignant hematology

Mucositis in patients with hematologic malignancies: an overview.

NOTCH1 mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation treatment.

Opioids in pain management of blood-related malignancies.

Pain and related complaints in patients with acute leukemia: time for simultaneous care in hemato-oncology

Pain in blood cancers

Pain in malignant hematology ⬇️

Pain management in hematological patients with major organ dysfunctions and comorbid illnesses

Pain management in multiple myeloma.

Pain syndromes in haematological malignancies: an overview

Pain syndromes in sickle cell disease: an update

Palifermin in the management of mucositis in hematological malignancies: current evidences and future perspectives.

Patient-reported outcomes enhance the survival prediction of traditional disease risk classifications: An international study in patients with myelodysplastic syndromes

Prevalence, severity and correlates of fatigue in newly diagnosed patients with myelodysplastic syndromes

Primary acquired chronic pure red cell aplasia refractory to standard treatments: remission with rituximab.

Primary pulmonary hodgkin lymphoma simulating a mediastinal tumour: an uncommon occurrence.

Prognostic value of self-reported fatigue on overall survival in patients with myelodysplastic syndromes: a multicentre, prospective, observational, cohort study

Pulmonary infections in patients with myelodysplastic syndromes receiving frontline azacytidine treatment

Pure erythroid leukemia in advanced breast cancer.

Real-life use of erythropoiesis-stimulating agents in myelodysplastic syndromes: a "Gruppo Romano Mielodisplasie (GROM)" multicenter study.

Reciprocal absence of cross-resistance between eltrombopag and romiplostim in two patients with refractory immune thrombocytopenic purpura

Regaining the response to erythropoietin following azacitidine in chronic myelomonocytic leukemia previously evolved from refractory anemia

Role of immunochemotherapy in the treatment of chronic lymphocytic leukemia

Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia.

Steroid-refractory immune thrombocytopenia in the era of the new thrombomimetic drugs: is there still a role for rituximab?

Systematic review of amifostine for the management of oral mucositis in cancer patients

Systematic review of anti-inflammatory agents for the management of oral mucositis in cancer patients.

The management of membranous glomerulopathy in allogeneic stem cells transplantation: updated literature

The prevention of oral mucositis in patients with blood cancers: current concepts and emerging landscapes

The use of major analgesics in patients with renal dysfunction.

Towards the integration of patient-reported outcomes into the global clinical management of multiple myeloma

Unexplained severe Coombs-negative hemolytic anemia during treatment of refractory chronic lymphocytic leukemia with alemtuzumab.